PL1667523T3 - Kompozycje szczepionki dna i sposoby stosowania - Google Patents

Kompozycje szczepionki dna i sposoby stosowania

Info

Publication number
PL1667523T3
PL1667523T3 PL04784389T PL04784389T PL1667523T3 PL 1667523 T3 PL1667523 T3 PL 1667523T3 PL 04784389 T PL04784389 T PL 04784389T PL 04784389 T PL04784389 T PL 04784389T PL 1667523 T3 PL1667523 T3 PL 1667523T3
Authority
PL
Poland
Prior art keywords
methods
vaccine compositions
dna vaccine
dna
compositions
Prior art date
Application number
PL04784389T
Other languages
English (en)
Inventor
Opendra Narayan
Zhenqian Liu
Original Assignee
Univ Of Kansas Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Of Kansas Medical Center filed Critical Univ Of Kansas Medical Center
Publication of PL1667523T3 publication Critical patent/PL1667523T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL04784389T 2003-09-16 2004-09-16 Kompozycje szczepionki dna i sposoby stosowania PL1667523T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50319703P 2003-09-16 2003-09-16
US10/941,164 US7488485B2 (en) 2003-09-16 2004-09-15 DNA vaccine compositions and methods of use
PCT/US2004/030512 WO2005027844A2 (en) 2003-09-16 2004-09-16 Dna vaccine compositions and methods of use
EP04784389A EP1667523B1 (en) 2003-09-16 2004-09-16 Dna vaccine compositions and methods of use

Publications (1)

Publication Number Publication Date
PL1667523T3 true PL1667523T3 (pl) 2013-05-31

Family

ID=34381064

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04784389T PL1667523T3 (pl) 2003-09-16 2004-09-16 Kompozycje szczepionki dna i sposoby stosowania

Country Status (13)

Country Link
US (3) US7488485B2 (pl)
EP (1) EP1667523B1 (pl)
JP (1) JP4989224B2 (pl)
AU (1) AU2004273965B2 (pl)
BR (1) BRPI0414442A (pl)
CA (1) CA2538840C (pl)
DK (1) DK1667523T3 (pl)
ES (1) ES2399875T3 (pl)
IL (1) IL174325A (pl)
NZ (1) NZ545954A (pl)
PL (1) PL1667523T3 (pl)
PT (1) PT1667523E (pl)
WO (1) WO2005027844A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488485B2 (en) * 2003-09-16 2009-02-10 University Of Kansas Medical Center DNA vaccine compositions and methods of use
US8765140B2 (en) * 2003-09-16 2014-07-01 University Of Kansas Medical Center DNA vaccine compositions with HIV/SIV gene modifications
ES2541771T3 (es) * 2005-05-03 2015-07-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Expresión de una proteína mitocondrial mediante un enfoque alotópico mejorado
US7585675B2 (en) * 2005-11-15 2009-09-08 University Of Kansas Medical Center Inhibition of HIV and SHIV replication with antisense interleukin-4
FR2979919B1 (fr) * 2011-09-12 2015-12-11 Centre Nat Rech Scient Genomes lentiviraux chimeriques non-integratifs comme vaccins innovants contre vih-1
US20130337009A1 (en) * 2012-02-21 2013-12-19 Immunogenetix Therapeutics, Inc. Chimeric dna vaccine compositions and methods of use
AU2020315598B2 (en) 2019-07-16 2024-12-12 Gilead Sciences, Inc. HIV vaccines and methods of making and using
CA3202466A1 (en) 2021-01-14 2022-07-21 Jiani LI Hiv vaccines and methods of using
AU2022208435A1 (en) 2021-01-18 2023-08-10 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741492A (en) * 1996-01-23 1998-04-21 St. Jude Children's Research Hospital Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
US6531123B1 (en) * 1997-05-01 2003-03-11 Lung-Ji Chang Lentiviral vectors
US7488485B2 (en) * 2003-09-16 2009-02-10 University Of Kansas Medical Center DNA vaccine compositions and methods of use
US7122180B2 (en) * 2000-10-23 2006-10-17 Children's Medical Center Corporation DNA vectors containing mutated HIV proviruses

Also Published As

Publication number Publication date
WO2005027844A3 (en) 2005-10-06
JP4989224B2 (ja) 2012-08-01
DK1667523T3 (da) 2013-01-21
US7488485B2 (en) 2009-02-10
PT1667523E (pt) 2013-02-04
US20120207782A1 (en) 2012-08-16
IL174325A (en) 2015-07-30
US8003113B2 (en) 2011-08-23
US20050112102A1 (en) 2005-05-26
US20090233857A1 (en) 2009-09-17
AU2004273965A1 (en) 2005-03-31
CA2538840C (en) 2014-02-18
CA2538840A1 (en) 2005-03-31
US8916174B2 (en) 2014-12-23
NZ545954A (en) 2009-04-30
ES2399875T3 (es) 2013-04-04
EP1667523B1 (en) 2012-11-21
WO2005027844A2 (en) 2005-03-31
EP1667523A2 (en) 2006-06-14
IL174325A0 (en) 2008-04-13
AU2004273965B2 (en) 2010-12-09
EP1667523A4 (en) 2007-12-19
JP2007505923A (ja) 2007-03-15
BRPI0414442A (pt) 2006-11-14

Similar Documents

Publication Publication Date Title
SG2009050212A (en) Severe acute respiratory syndrome dna vaccine compositions and methods of use
IL172689A0 (en) Pro104 ANTIBODY COMPOSITIONS AND METHODS OF USE
AU2003259735A8 (en) Small-mer compositions and methods of use
AU2003239129A8 (en) Methods and compositions for dna manipulation
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
IL219406A0 (en) Antiloading compositions and methods of selecting same
GB0411940D0 (en) Methods and compositions
IL218357A0 (en) Compositions and methods of using angiopoietin-like 4 protein
IL172647A0 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
AU2003299441A8 (en) Nf-hev compositions and methods of use
TWI339662B (en) Arylvinylazacycloalkane compounds and methods of preparation and use thereof
GB0303609D0 (en) Novel therapeutic method and compositions
IL174325A0 (en) Dna vaccine compositions and methods of use
PT1667693E (pt) Composições e métodos para usar corpos lamelares com fins terapêuticos
EP1583557A4 (en) VACCINE COMPOSITIONS AND METHODS
GB0324523D0 (en) Compositions and methods of treatment
IL180195A0 (en) Aequorin-containing compositions and methods of using same
IL175746A0 (en) Oral formulations of desoxypeganine and uses thereof
GB0327050D0 (en) Therapeutic methods compositions and uses
GB0303600D0 (en) Novel therapeutic method and compositions
AU2003300770A8 (en) Cardiolipin compositions their methods of preparation and use
HK1087433A (en) Severe acute respiratory syndrome dna vaccine compositions and methods of use
PL1667693T3 (pl) Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych
GB0300455D0 (en) Meyhod of vaccine preparation
GB0326870D0 (en) Therapeutic methods and compositions for use therein